Locations
San Jose, CA, USA · Menlo Park, CA, USA · Stokes, San Jose, CA, USA
industry
Biotechnology · Biotechnology Research · Health Care · Medical · Therapeutics
Size
11 - 50 employees
Stage
Other
founded in
2017
Allay is pioneering a new category of ultra-sustained pain therapeutics to transform post-surgical pain management and recuperation for patients and physicians. Allay’s proprietary technology platform combines validated non-opioid analgesics and biopolymers to create dissolvable therapeutics to deliver pain relief within a targeted site over weeks—an order of magnitude greater than the longest-lasting pain treatments currently available. The company’s lead investigational product candidate, ATX101, is currently being evaluated in a Phase 2 clinical study in TKA surgeries. Allay unites a dynamic, global team of entrepreneurs, scientists, clinicians, and innovators in the San Francisco Bay Area and Singapore.
Something looks off?